Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures

Cancer Research

Volumn 66, Issue 5, 2006, Pages 2608-2615

  Van Schanke, Arne ^a,b,d   Van Venrooij, Gemma M C A L ^b   Jongsma, Marjan J ^b   Banus, H Alexander ^c   Mullenders, Leon H F ^b   Van Kranen, Henk J ^c   De Gruijl, Frank R ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; DIMETHYLBENZ[A]ANTHRACENE; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL EXPERIMENT; ARTICLE; BRAF GENE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; GENE; GENE MUTATION; GENETIC ANALYSIS; HIGH RISK PATIENT; KNOCKOUT GENE; LONG TERM EXPOSURE; MELANOMA; MOUSE; NEVUS; NEWBORN PERIOD; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; SKIN TUMOR; ULTRAVIOLET RADIATION; XERODERMA PIGMENTOSUM;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOMA, SQUAMOUS CELL; COCARCINOGENESIS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; MELANOMA, EXPERIMENTAL; MICE; MICE, KNOCKOUT; NEOPLASMS, RADIATION-INDUCED; NEVUS; SARCOMA; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P14ARF; ULTRAVIOLET RAYS; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

EID: 33645083459     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-2476     Document Type: Article

References (37)

1. Elwood JM, Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer 1997; 73:198-203.
2. Hayward NK. Genetics of melanoma predisposition. Oncogene 2003;22:3053-62.
3. Sharpless NE, De Pinho RA. The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev 1999; 9:22-30.
4. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998;92:713-23.
5. Eskandarpour M, Hashemi J, Kanter L, et al. Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations. JNCI Cancer Spectrum 2003;95:790.
6. Serrano M, Lee H, Chin L, et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996; 85:27-37.
7. Sharpless NE, Kannan K, Xu J, Bosenberg MW, Chin L. Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo. Oncogene 2003;22:5055-9.
8. Daniotti M, Oggionni M, Ranzani T, et al. BRAF alterations are associated with complex mutational profiles in malignant melanoma. Oncogene 2004;23:5968-77.
9. Keller-Melchior R, Schmidt R, Piepkorn M. Expression of the tumor suppressor gene product p16INK4 in benign and malignant melanocytic lesions. J Invest Dermatol 1998;110:932-8.
10. Bennett DC. Human melanocyte senescence and melanoma susceptibility genes. Oncogene 2003;22:3063-9.
11. Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A 1991;88:10124-8.
12. Daya-Grosjean L, Sarasin A. UV-specific mutations of the human patched gene in basal cell carcinomas from normal individuals and xeroderma pigmentosum patients. Mutat Res 2000;450:193-9.
13. Kraemer KH, Lee MM, Andrews AD, Lambert WC. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 1994;130:1018-21.
14. Epstein JH, Epstein WL, Nakai T. Production of melanomas from DMBA-induced "blue nevi" in hairless mice with ultraviolet light. J Natl Cancer Inst 1967;38:19-30.
15. Romerdahl CA, Stephens LC, Bucana C, Kripke ML. The role of ultraviolet radiation in the induction of melanocytic skin tumors in inbred mice. Cancer Commun 1989;1:209-16.
16. Husain Z, Pathak MA, Flotte T, Wick MM. Role of ultraviolet radiation in the induction of melanocytic tumors in hairless mice following 7,12-dimethylbenz (a)anthracene application and ultraviolet irradiation. Cancer Res 1991;51:4964-70.
17. de Gruijl FR, van Kranen HJ, van Schanke A. UV exposure, genetic targets in melanocytic tumors and transgenic mouse models. Photochem Photobiol 2005; 81:52-64.
18. Chin L, Pomerantz J, Polsky D, et al. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev 1997;11:2822-34.
19. de Vries A, Berg RJ, Wijnhoven S, et al. XPA-deficiency in hairless mice causes a shift in skin tumor types and mutational target genes after exposure to low doses of U.V.B. Oncogene 1998;16:2205-12.
20. Soufir N, Moles JP, Vilmer C, et al. P16 UV mutations in human skin epithelial tumors. Oncogene 1999;18:5477-81.
21. de Vries A, van Oostrom CT, Hofhuis FM, et al. Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature 1995;377:169-73.
22. Rebel H, Mosnier LO, Berg RJ, et al. Early p53-positive foci as indicators of tumor risk in ultraviolet-exposed hairless mice: kinetics of induction, effects of DNA repair deficiency, and p53 heterozygosity. Cancer Res 2001;61:977-83.
23. Berg RJ, de Vries A, van Steeg H, de Gruijl FR. Relative susceptibilities of XPA knockout mice and their heterozygous and wild-type littermates to UVB-induced skin cancer. Cancer Res 1997;57:581-4.
24. Rebel H, van Steeg H, Beems RB, et al. Suppression of UV carcinogenesis by difluoromethylornithine in nucleotide excision repair-deficient Xpa knockout mice. Cancer Res 2002;62:1338-42.
25. Holman CD, Armstrong BK. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 1984;73:75-82.
26. van Schanke A, Jongsma MJ, Bisschop R, et al. Single UVB overexposure stimulates melanocyte proliferation in murine skin, in contrast to fractionated or UVA-1 exposure. J Invest Dermatol 2005;124:241-7.
27. Tronnier M, Rudolph P, Koser T, Raasch B, Brinckmann J. One single erythemagenic UV irradiation is more effective in increasing the proliferative activity of melanocytes in melanocytic naevi compared with fractionally applied high doses. Br J Dermatol 1997;137:534-9.
28. Ahn GY, Butt KI, Jindo T, et al. The expression of endothelin-1 and its binding sites in mouse skin increased after ultraviolet B irradiation or local injection of tumor necrosis factor α. J Dermatol 1998;25:78-84.
29. Kligman LH, Murphy GF. Ultraviolet B radiation increases hairless mouse mast cells in a dose-dependent manner and alters distribution of UV-induced mast cell growth factor. Photochem Photobiol 1996;63:123-7.
30. Hachiya A, Kobayashi A, Ohuchi A, Takema Y, Imokawa G. The paracrine role of stem cell factor/c-kit signaling in the activation of human melanocytes in ultraviolet-B-induced pigmentation. J Invest Dermatol 2001;116:578-86.
31. Powell MB, Gause PR, Hyman P, et al. Induction of melanoma in TPras transgenic mice. Carcinogenesis 1999;20:1747-53.
32. Dulon M, Weichenthal M, Blettner M, et al. Sun exposure and number of nevi in 5- to 6-year-old European children. J Clin Epidemiol 2002;55:1075-81.
33. INK4a in cell cycle delays after low dose UV radiation. Mutat Res 1998;422:43-53.
34. Noonan FP, Recio JA, Takayama H, et al. Neonatal sunburn and melanoma in mice. Nature 2001;413:271-2.
35. Ink4a confers susceptibility to metastatic melanoma in mice. Nature 2001;413:83-6.
36. Mann SJ. Hair loss and cyst formation in hairless and rhino mutant mice. Anat Rec 1971;170:485-99.
37. Forbes PD, Davies RE. Photocarcinogenesis in hairless mice: dose response and influence of dose-delivery. In: Daynes RA, Spikes JD, editors. Experimental and Clinical Photoimmunology. Vol. 1. Boca Raton (Florida): CRC Press; 1983. p. 43-60.